Intrinsic molecular subtypes of HER2+ breast cancer

Por Prat, Aleix, Pascual, Tomás, Adamo, Barbara
Publicado no Oncotarget (2017)

De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance

Por Veeraraghavan, Jamunarani, De Angelis, Carmine, Reis-Filho, Jorge S., Prat, Aleix, Rimawi, Mothaffar F., Pascual, Tomás, Osborne, C. Kent, Schiff, Rachel
Publicado no Breast (2017)

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases

Por Laimito, Katerin Rojas, Gámez-Pozo, Angelo, Sepúlveda, Juan, Manso, Luis, López-Vacas, Rocío, Pascual, Tomás, Fresno Vara, Juan A, Ciruelos, Eva
Publicado no Ecancermedicalscience (2016)

Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer

Por Pascual, Tomas, Apellániz-Ruiz, María, Pernaut, Cristina, Cueto-Felgueroso, Cecilia, Villalba, Pablo, Álvarez, Carlos, Manso, Luis, Inglada-Pérez, Lucia, Robledo, Mercedes, Rodríguez-Antona, Cristina, Ciruelos, Eva
Publicado no PLoS One (2017)

Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer

Por Fernand ez-Martinez, Aranzazu, Pascual, Tomás, Perrone, Giuseppe, Morales, Serafin, de la Haba, Juan, González-Rivera, Milagros, Galván, Patricia, Zalfa, Francesca, Amato, Michela, Gonzalez, Lucia, Prats, Miquel, Rojo, Federico, Manso, Luis, Paré, Laia, Alonso, Immaculada, Albanell, Joan, Vivancos, Ana, González, Antonio, Matito, Judit, González, Sonia, Fernandez, Pedro, Adamo, Barbara, Muñoz, Montserrat, Viladot, Margarita, Font, Carme, Aya, Francisco, Vidal, Maria, Caballero, Rosalía, Carrasco, Eva, Altomare, Vittorio, Tonini, Giuseppe, Prat, Aleix, Martin, Miguel
Publicado no Oncotarget (2017)